IBDEI0DO ; ; 03-MAY-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34300,2)
 ;;=^5159288
 ;;^UTILITY(U,$J,358.3,34301,0)
 ;;=G44.1^^105^1431^10
 ;;^UTILITY(U,$J,358.3,34301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34301,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,34301,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,34301,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,34302,0)
 ;;=G43.909^^105^1431^6
 ;;^UTILITY(U,$J,358.3,34302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34302,1,3,0)
 ;;=3^Migraine,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,34302,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,34302,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,34303,0)
 ;;=G44.009^^105^1431^1
 ;;^UTILITY(U,$J,358.3,34303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34303,1,3,0)
 ;;=3^Cluster Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,34303,1,4,0)
 ;;=4^G44.009
 ;;^UTILITY(U,$J,358.3,34303,2)
 ;;=^5003921
 ;;^UTILITY(U,$J,358.3,34304,0)
 ;;=G44.40^^105^1431^5
 ;;^UTILITY(U,$J,358.3,34304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34304,1,3,0)
 ;;=3^Medication Overuse Headache,Not Intractable
 ;;^UTILITY(U,$J,358.3,34304,1,4,0)
 ;;=4^G44.40
 ;;^UTILITY(U,$J,358.3,34304,2)
 ;;=^5003947
 ;;^UTILITY(U,$J,358.3,34305,0)
 ;;=G44.89^^105^1431^2
 ;;^UTILITY(U,$J,358.3,34305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34305,1,3,0)
 ;;=3^Headache Syndrome NEC
 ;;^UTILITY(U,$J,358.3,34305,1,4,0)
 ;;=4^G44.89
 ;;^UTILITY(U,$J,358.3,34305,2)
 ;;=^5003954
 ;;^UTILITY(U,$J,358.3,34306,0)
 ;;=G44.84^^105^1431^8
 ;;^UTILITY(U,$J,358.3,34306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34306,1,3,0)
 ;;=3^Primary Exertional Headache
 ;;^UTILITY(U,$J,358.3,34306,1,4,0)
 ;;=4^G44.84
 ;;^UTILITY(U,$J,358.3,34306,2)
 ;;=^336563
 ;;^UTILITY(U,$J,358.3,34307,0)
 ;;=G44.301^^105^1431^7
 ;;^UTILITY(U,$J,358.3,34307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34307,1,3,0)
 ;;=3^Post-Traumatic Headache,Unspec,Intractable
 ;;^UTILITY(U,$J,358.3,34307,1,4,0)
 ;;=4^G44.301
 ;;^UTILITY(U,$J,358.3,34307,2)
 ;;=^5003941
 ;;^UTILITY(U,$J,358.3,34308,0)
 ;;=G44.209^^105^1431^9
 ;;^UTILITY(U,$J,358.3,34308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34308,1,3,0)
 ;;=3^Tension-Type Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,34308,1,4,0)
 ;;=4^G44.209
 ;;^UTILITY(U,$J,358.3,34308,2)
 ;;=^5003936
 ;;^UTILITY(U,$J,358.3,34309,0)
 ;;=R51.0^^105^1431^3
 ;;^UTILITY(U,$J,358.3,34309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34309,1,3,0)
 ;;=3^Headache w/ Orthostatic Component,NEC
 ;;^UTILITY(U,$J,358.3,34309,1,4,0)
 ;;=4^R51.0
 ;;^UTILITY(U,$J,358.3,34309,2)
 ;;=^5159305
 ;;^UTILITY(U,$J,358.3,34310,0)
 ;;=R51.9^^105^1431^4
 ;;^UTILITY(U,$J,358.3,34310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34310,1,3,0)
 ;;=3^Headache,Unspec
 ;;^UTILITY(U,$J,358.3,34310,1,4,0)
 ;;=4^R51.9
 ;;^UTILITY(U,$J,358.3,34310,2)
 ;;=^5159306
 ;;^UTILITY(U,$J,358.3,34311,0)
 ;;=I30.0^^105^1432^5
 ;;^UTILITY(U,$J,358.3,34311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34311,1,3,0)
 ;;=3^Idiopathic Pericarditis,Acute Nonspec
 ;;^UTILITY(U,$J,358.3,34311,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,34311,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,34312,0)
 ;;=I34.8^^105^1432^6
 ;;^UTILITY(U,$J,358.3,34312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34312,1,3,0)
 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
 ;;^UTILITY(U,$J,358.3,34312,1,4,0)
 ;;=4^I34.8
 ;;^UTILITY(U,$J,358.3,34312,2)
 ;;=^5007172
 ;;^UTILITY(U,$J,358.3,34313,0)
 ;;=I34.0^^105^1432^13
 ;;^UTILITY(U,$J,358.3,34313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34313,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,34313,1,4,0)
 ;;=4^I34.0
 ;;^UTILITY(U,$J,358.3,34313,2)
 ;;=^5007169
 ;;^UTILITY(U,$J,358.3,34314,0)
 ;;=I34.9^^105^1432^12
 ;;^UTILITY(U,$J,358.3,34314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34314,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,34314,1,4,0)
 ;;=4^I34.9
 ;;^UTILITY(U,$J,358.3,34314,2)
 ;;=^5007173
 ;;^UTILITY(U,$J,358.3,34315,0)
 ;;=I34.2^^105^1432^7
 ;;^UTILITY(U,$J,358.3,34315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34315,1,3,0)
 ;;=3^Nonrhematic Mitral Valve Stenosis
 ;;^UTILITY(U,$J,358.3,34315,1,4,0)
 ;;=4^I34.2
 ;;^UTILITY(U,$J,358.3,34315,2)
 ;;=^5007171
 ;;^UTILITY(U,$J,358.3,34316,0)
 ;;=I35.0^^105^1432^10
 ;;^UTILITY(U,$J,358.3,34316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34316,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,34316,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,34316,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,34317,0)
 ;;=I35.1^^105^1432^9
 ;;^UTILITY(U,$J,358.3,34317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34317,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,34317,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,34317,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,34318,0)
 ;;=I35.2^^105^1432^11
 ;;^UTILITY(U,$J,358.3,34318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34318,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,34318,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,34318,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,34319,0)
 ;;=I35.9^^105^1432^8
 ;;^UTILITY(U,$J,358.3,34319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34319,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,34319,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,34319,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,34320,0)
 ;;=I38.^^105^1432^4
 ;;^UTILITY(U,$J,358.3,34320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34320,1,3,0)
 ;;=3^Endocarditis,Valve Unspec
 ;;^UTILITY(U,$J,358.3,34320,1,4,0)
 ;;=4^I38.
 ;;^UTILITY(U,$J,358.3,34320,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,34321,0)
 ;;=I05.0^^105^1432^18
 ;;^UTILITY(U,$J,358.3,34321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34321,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,34321,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,34321,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,34322,0)
 ;;=I05.8^^105^1432^19
 ;;^UTILITY(U,$J,358.3,34322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34322,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,34322,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,34322,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,34323,0)
 ;;=I05.9^^105^1432^20
 ;;^UTILITY(U,$J,358.3,34323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34323,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,34323,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,34323,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,34324,0)
 ;;=I07.1^^105^1432^21
 ;;^UTILITY(U,$J,358.3,34324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34324,1,3,0)
 ;;=3^Rheumatic Tricuspid Insufficiency
 ;;^UTILITY(U,$J,358.3,34324,1,4,0)
 ;;=4^I07.1
 ;;^UTILITY(U,$J,358.3,34324,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,34325,0)
 ;;=I07.9^^105^1432^22
 ;;^UTILITY(U,$J,358.3,34325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34325,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,34325,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,34325,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,34326,0)
 ;;=I08.0^^105^1432^16
 ;;^UTILITY(U,$J,358.3,34326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34326,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,34326,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,34326,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,34327,0)
 ;;=I09.89^^105^1432^17
 ;;^UTILITY(U,$J,358.3,34327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34327,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,34327,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,34327,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,34328,0)
 ;;=I47.1^^105^1432^24
 ;;^UTILITY(U,$J,358.3,34328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34328,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,34328,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,34328,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,34329,0)
 ;;=I48.0^^105^1432^15
 ;;^UTILITY(U,$J,358.3,34329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34329,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,34329,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,34329,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,34330,0)
 ;;=I49.5^^105^1432^23
 ;;^UTILITY(U,$J,358.3,34330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34330,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,34330,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,34330,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,34331,0)
 ;;=I49.8^^105^1432^3
 ;;^UTILITY(U,$J,358.3,34331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34331,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,34331,1,4,0)
 ;;=4^I49.8
 ;;^UTILITY(U,$J,358.3,34331,2)
 ;;=^5007236
 ;;^UTILITY(U,$J,358.3,34332,0)
 ;;=I49.9^^105^1432^2
 ;;^UTILITY(U,$J,358.3,34332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34332,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,34332,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,34332,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,34333,0)
 ;;=R00.1^^105^1432^1
 ;;^UTILITY(U,$J,358.3,34333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34333,1,3,0)
 ;;=3^Bradycardia,Unspec
 ;;^UTILITY(U,$J,358.3,34333,1,4,0)
 ;;=4^R00.1
 ;;^UTILITY(U,$J,358.3,34333,2)
 ;;=^5019164
 ;;^UTILITY(U,$J,358.3,34334,0)
 ;;=I34.1^^105^1432^14
 ;;^UTILITY(U,$J,358.3,34334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34334,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,34334,1,4,0)
 ;;=4^I34.1
 ;;^UTILITY(U,$J,358.3,34334,2)
 ;;=^5007170
 ;;^UTILITY(U,$J,358.3,34335,0)
 ;;=D68.4^^105^1433^1
 ;;^UTILITY(U,$J,358.3,34335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34335,1,3,0)
 ;;=3^Acquired Coagulation Factor Deficiency
 ;;^UTILITY(U,$J,358.3,34335,1,4,0)
 ;;=4^D68.4
 ;;^UTILITY(U,$J,358.3,34335,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,34336,0)
 ;;=D59.9^^105^1433^2
 ;;^UTILITY(U,$J,358.3,34336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34336,1,3,0)
 ;;=3^Acquired Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,34336,1,4,0)
 ;;=4^D59.9
 ;;^UTILITY(U,$J,358.3,34336,2)
 ;;=^5002330
 ;;^UTILITY(U,$J,358.3,34337,0)
 ;;=C91.00^^105^1433^5
 ;;^UTILITY(U,$J,358.3,34337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34337,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,34337,1,4,0)
 ;;=4^C91.00
 ;;^UTILITY(U,$J,358.3,34337,2)
 ;;=^5001762
 ;;^UTILITY(U,$J,358.3,34338,0)
 ;;=C91.01^^105^1433^4
 ;;^UTILITY(U,$J,358.3,34338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34338,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,34338,1,4,0)
 ;;=4^C91.01
 ;;^UTILITY(U,$J,358.3,34338,2)
 ;;=^5001763
 ;;^UTILITY(U,$J,358.3,34339,0)
 ;;=C92.01^^105^1433^7
 ;;^UTILITY(U,$J,358.3,34339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34339,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,34339,1,4,0)
 ;;=4^C92.01
 ;;^UTILITY(U,$J,358.3,34339,2)
 ;;=^5001790
 ;;^UTILITY(U,$J,358.3,34340,0)
 ;;=C92.00^^105^1433^8
 ;;^UTILITY(U,$J,358.3,34340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34340,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,34340,1,4,0)
 ;;=4^C92.00
 ;;^UTILITY(U,$J,358.3,34340,2)
 ;;=^5001789
 ;;^UTILITY(U,$J,358.3,34341,0)
 ;;=C92.61^^105^1433^9
 ;;^UTILITY(U,$J,358.3,34341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34341,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
 ;;^UTILITY(U,$J,358.3,34341,1,4,0)
 ;;=4^C92.61
 ;;^UTILITY(U,$J,358.3,34341,2)
 ;;=^5001808
 ;;^UTILITY(U,$J,358.3,34342,0)
 ;;=C92.60^^105^1433^10
 ;;^UTILITY(U,$J,358.3,34342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34342,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
 ;;^UTILITY(U,$J,358.3,34342,1,4,0)
 ;;=4^C92.60
 ;;^UTILITY(U,$J,358.3,34342,2)
 ;;=^5001807
 ;;^UTILITY(U,$J,358.3,34343,0)
 ;;=C92.A1^^105^1433^11
 ;;^UTILITY(U,$J,358.3,34343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34343,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
 ;;^UTILITY(U,$J,358.3,34343,1,4,0)
 ;;=4^C92.A1
 ;;^UTILITY(U,$J,358.3,34343,2)
 ;;=^5001814
 ;;^UTILITY(U,$J,358.3,34344,0)
 ;;=C92.A0^^105^1433^12
 ;;^UTILITY(U,$J,358.3,34344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34344,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
 ;;^UTILITY(U,$J,358.3,34344,1,4,0)
 ;;=4^C92.A0
 ;;^UTILITY(U,$J,358.3,34344,2)
 ;;=^5001813
 ;;^UTILITY(U,$J,358.3,34345,0)
 ;;=C92.51^^105^1433^13
 ;;^UTILITY(U,$J,358.3,34345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34345,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,34345,1,4,0)
 ;;=4^C92.51
 ;;^UTILITY(U,$J,358.3,34345,2)
 ;;=^5001805
 ;;^UTILITY(U,$J,358.3,34346,0)
 ;;=C92.50^^105^1433^14
 ;;^UTILITY(U,$J,358.3,34346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34346,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,34346,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,34346,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,34347,0)
 ;;=C94.40^^105^1433^17
 ;;^UTILITY(U,$J,358.3,34347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34347,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
 ;;^UTILITY(U,$J,358.3,34347,1,4,0)
 ;;=4^C94.40
 ;;^UTILITY(U,$J,358.3,34347,2)
 ;;=^5001843
 ;;^UTILITY(U,$J,358.3,34348,0)
 ;;=C94.42^^105^1433^15
 ;;^UTILITY(U,$J,358.3,34348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34348,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
 ;;^UTILITY(U,$J,358.3,34348,1,4,0)
 ;;=4^C94.42
 ;;^UTILITY(U,$J,358.3,34348,2)
 ;;=^5001845
 ;;^UTILITY(U,$J,358.3,34349,0)
 ;;=C94.41^^105^1433^16
 ;;^UTILITY(U,$J,358.3,34349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34349,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
 ;;^UTILITY(U,$J,358.3,34349,1,4,0)
 ;;=4^C94.41
 ;;^UTILITY(U,$J,358.3,34349,2)
 ;;=^5001844
 ;;^UTILITY(U,$J,358.3,34350,0)
 ;;=D62.^^105^1433^18
 ;;^UTILITY(U,$J,358.3,34350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34350,1,3,0)
 ;;=3^Acute Posthemorrhagic Anemia
 ;;^UTILITY(U,$J,358.3,34350,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,34350,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,34351,0)
 ;;=C92.41^^105^1433^19
 ;;^UTILITY(U,$J,358.3,34351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34351,1,3,0)
 ;;=3^Acute Promyelocytic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,34351,1,4,0)
 ;;=4^C92.41
 ;;^UTILITY(U,$J,358.3,34351,2)
 ;;=^5001802
 ;;^UTILITY(U,$J,358.3,34352,0)
 ;;=C92.40^^105^1433^20
 ;;^UTILITY(U,$J,358.3,34352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34352,1,3,0)
 ;;=3^Acute Promyelocytic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,34352,1,4,0)
 ;;=4^C92.40
 ;;^UTILITY(U,$J,358.3,34352,2)
 ;;=^5001801
 ;;^UTILITY(U,$J,358.3,34353,0)
 ;;=D56.0^^105^1433^21
 ;;^UTILITY(U,$J,358.3,34353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34353,1,3,0)
 ;;=3^Alpha Thalassemia
 ;;^UTILITY(U,$J,358.3,34353,1,4,0)
 ;;=4^D56.0
 ;;^UTILITY(U,$J,358.3,34353,2)
 ;;=^340494
 ;;^UTILITY(U,$J,358.3,34354,0)
 ;;=D63.1^^105^1433^23
 ;;^UTILITY(U,$J,358.3,34354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34354,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,34354,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,34354,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,34355,0)
 ;;=D63.0^^105^1433^24
 ;;^UTILITY(U,$J,358.3,34355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34355,1,3,0)
 ;;=3^Anemia in Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,34355,1,4,0)
 ;;=4^D63.0
 ;;^UTILITY(U,$J,358.3,34355,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,34356,0)
 ;;=D63.8^^105^1433^22
 ;;^UTILITY(U,$J,358.3,34356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34356,1,3,0)
 ;;=3^Anemia in Chronic Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,34356,1,4,0)
 ;;=4^D63.8
 ;;^UTILITY(U,$J,358.3,34356,2)
 ;;=^5002343
 ;;^UTILITY(U,$J,358.3,34357,0)
 ;;=C22.3^^105^1433^27
 ;;^UTILITY(U,$J,358.3,34357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34357,1,3,0)
 ;;=3^Angiosarcoma of Liver
 ;;^UTILITY(U,$J,358.3,34357,1,4,0)
 ;;=4^C22.3
 ;;^UTILITY(U,$J,358.3,34357,2)
 ;;=^5000936
 ;;^UTILITY(U,$J,358.3,34358,0)
 ;;=D61.9^^105^1433^28
 ;;^UTILITY(U,$J,358.3,34358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34358,1,3,0)
 ;;=3^Aplastic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,34358,1,4,0)
 ;;=4^D61.9
 ;;^UTILITY(U,$J,358.3,34358,2)
 ;;=^5002342
 ;;^UTILITY(U,$J,358.3,34359,0)
 ;;=D56.1^^105^1433^34
 ;;^UTILITY(U,$J,358.3,34359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34359,1,3,0)
 ;;=3^Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,34359,1,4,0)
 ;;=4^D56.1
 ;;^UTILITY(U,$J,358.3,34359,2)
 ;;=^340495
 ;;^UTILITY(U,$J,358.3,34360,0)
 ;;=C83.79^^105^1433^36
 ;;^UTILITY(U,$J,358.3,34360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34360,1,3,0)
 ;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,34360,1,4,0)
 ;;=4^C83.79
 ;;^UTILITY(U,$J,358.3,34360,2)
 ;;=^5001600
 ;;^UTILITY(U,$J,358.3,34361,0)
 ;;=C83.70^^105^1433^37
 ;;^UTILITY(U,$J,358.3,34361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34361,1,3,0)
 ;;=3^Burkitt Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,34361,1,4,0)
 ;;=4^C83.70
 ;;^UTILITY(U,$J,358.3,34361,2)
 ;;=^5001591
 ;;^UTILITY(U,$J,358.3,34362,0)
 ;;=D09.0^^105^1433^44
 ;;^UTILITY(U,$J,358.3,34362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34362,1,3,0)
 ;;=3^Carcinoma in Situ of Bladder
 ;;^UTILITY(U,$J,358.3,34362,1,4,0)
 ;;=4^D09.0
 ;;^UTILITY(U,$J,358.3,34362,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,34363,0)
 ;;=D06.9^^105^1433^45
 ;;^UTILITY(U,$J,358.3,34363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34363,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix
 ;;^UTILITY(U,$J,358.3,34363,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,34363,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,34364,0)
 ;;=D06.0^^105^1433^47
 ;;^UTILITY(U,$J,358.3,34364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34364,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,34364,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,34364,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,34365,0)
 ;;=D06.1^^105^1433^48
 ;;^UTILITY(U,$J,358.3,34365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34365,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,34365,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,34365,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,34366,0)
 ;;=D06.7^^105^1433^46
 ;;^UTILITY(U,$J,358.3,34366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34366,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Other Parts
 ;;^UTILITY(U,$J,358.3,34366,1,4,0)
 ;;=4^D06.7
 ;;^UTILITY(U,$J,358.3,34366,2)
 ;;=^5001940
 ;;^UTILITY(U,$J,358.3,34367,0)
 ;;=D04.9^^105^1433^49
 ;;^UTILITY(U,$J,358.3,34367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34367,1,3,0)
 ;;=3^Carcinoma in Situ of Skin
 ;;^UTILITY(U,$J,358.3,34367,1,4,0)
 ;;=4^D04.9
 ;;^UTILITY(U,$J,358.3,34367,2)
 ;;=^5001925
 ;;^UTILITY(U,$J,358.3,34368,0)
 ;;=C91.11^^105^1433^52
 ;;^UTILITY(U,$J,358.3,34368,1,0)
 ;;=^358.31IA^4^2
